The WATCHMAN(TM) Left Atrial Appendage Closure Device from Boston Scientific is an implant used to block the left atrial appendage of the heart, a common area for blood clot formations in patients ...

Boston Scientific’s Watchman left atrial appendage (LAA) closure device to prevent stroke resulted in significantly less bleeding after an ablation procedure than taking blood thinners ...

MIDDLETOWN TOWNSHIP, PA — St. Mary Medical Center is the first hospital in Bucks County to implant the new Watchman FLX Pro Left Atrial Appendage Closure (LAAC) Device. The device features the ...

The Watchman FLX device demonstrated superior safety and reduced bleeding risk compared to oral anticoagulation. Findings may prompt guideline changes, suggesting left atrial appendage closure as ...

WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) device, enhancing stroke prevention options for patients with non-valvular ...

Researchers estimate the current national prevalence of patients living with Afib – an irregular heartbeat that feels like a ...

establishing uniform coverage for percutaneous left atrial appendage closure (LAAC) devices such as the Watchman procedure. However, individuals must meet specific criteria. Learn more about the ...

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global clinical trial for its WATCHMAN ... Atrial Appendage Closure (“LAAC”) device.